Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Host cell entry and neutralisation sensitivity of H3N2 influenza A virus subclade K
AuthorsNicole Moor; Nianzhen Chen; Georg M. N. Behrens; Lu Zhang; Anna-Sophie Moldenhauer; Michael Winkler; Christine Happle; Sandra Steffens; Metodi V. Stankov; Karsten Lürken; Stefan Pöhlmann; Markus Hoffmann
Affiliations1. Infection Biology Unit, German Primate Center – Leibniz Institute for Primate Research, Göttingen, Germany; 2. Faculty of Biology and Psychology, Georg-August-University Göttingen, Göttingen, Germany; 3. Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany; 4. Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany; 5. German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Hannover, Germany; 6. Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany; 7. German Center for Lung Research, Biomedical Research in End-Stage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany; 8. Department of Pediatric Pulmonology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany; 9. Department of Medical Education, Hannover Medical School, Hannover, Germany; 10. Dialysis Centre Eickenhof, Langenhagen, Germany; 11. German Center for Infection Research (DZIF), Associated Partner Site Göttingen, Göttingen, Germany
Vaccine preparedness for Bundibugyo virus and lessons learned
AuthorsMichel Pletschette; Nadine Biedenkopf
Affiliations1. LMU University Hospital, Institute of Infectious Diseases and Tropical Medicine, Munich, Germany; 2. Institute of Virology, Marburg University, Marburg, Germany; 3. TTU Emerging Infections, German Center for Infection Research (DZIF), partner site Giessen-Marburg-Langen, Marburg, Germany
Vaccine acceptance in a future pandemic after COVID-19 and its decision drivers in Japan
AuthorsJunna Kawasaki; Masakaze Hamada; Masaki Machida; Ryo Komorizono; Mie Kobayashi-Ishihara; Naoko Fujita; Takahiro Tabuchi; Yuki Furuse
Affiliations1. Department of Infectious Disease Pathobiology, Graduate School of Medicine, Chiba University, Chiba, Japan; 2. Department of Microbiology and Infection; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA); The University of Tokyo, Tokyo, Japan; 3. Department of Preventive Medicine and Public Health, Tokyo Medical University, Tokyo, Japan; 4. Division of Epidemiology, School of Public Health, Graduate School of Medicine, Tohoku University, Sendai, Japan
Vaccinology in the twenty-first century revisited
AuthorsAlan D. T. Barrett; Richard E. Rupp; Richard W. Titball; Veronika von Messling
Affiliations1. Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, USA; 2. Department of Pathology, University of Texas Medical Branch, Galveston, USA; 3. Department of Pediatrics, University of Texas Medical Branch, Galveston, USA; 4. Department of Biosciences, University of Exeter, Exeter, UK; 5. Federal Ministry of Research, Technology and Space, Berlin, Germany
Report from the inaugural 2025 Asia-UK Maternal-Neonatal Infection and Immunity Network (AMMuNet) symposium
AuthorsSuraj Bhattarai; Pritha Adhikari; Kalpana Subedi; Anjila Ghimire; Simon B. Drysdale; Kirsty Le Doare; Gaurav Kwatra; Paul T. Heath
Affiliations1. Global Health Research and Medical Interventions Institute, Kathmandu, Nepal; 2. Department of Infectious Disease Epidemiology and International Health, London School of Hygiene & Tropical Medicine, London, UK; 3. Paropakar Maternity and Women’s Hospital, Government of Nepal, Kathmandu, Nepal; 4. Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; 5. Institute for Infection and Immunity, City St. George’s, University of London, London, UK; 6. Division of Infectious Diseases, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center and University of Cincinnati, Cincinnati, USA; 7. Department of Clinical Microbiology, Christian Medical College, Vellore, India
Scientific synergy between prophylactic and therapeutic HIV vaccines—prevention and cure
AuthorsMilton Maciel; Lindsey R. Baden; Katharine J. Bar; Thomas Calder; Angela Malaspina; Maurine D. Miner; Stuart Z. Shapiro; M. Patricia D’Souza
Affiliations1. Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, USA; 2. Brigham and Women’s Hospital and Harvard Medical School, Boston, USA; 3. Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA; 4. Fred Hutchtinson Cancer Center, Seattle, USA
Effect of a spore-based Mannheimia haemolytica vaccine on immune responses and respiratory microbiota in sheep
AuthorsMuhammed Salah Uddin; José Ortiz Guluarte; Timothy D. Schwinghamer; Daniel R. Barreda; Tim A. McAllister; Le Luo Guan; Trevor W. Alexander
Affiliations1. Lethbridge Research and Development Centre, Agriculture and Agri-Food Canada, Lethbridge, Canada; 2. Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Canada; 3. Department of Biological Sciences, University of Alberta, Edmonton, Canada; 4. Faculty of Land and Food Systems, University of British Columbia, Vancouver, Canada
A next-generation human lymphatic filariasis vaccine candidate, r Bm HAXT, for clinical development
AuthorsNithila Saravanan; Sean A. Gray; Jennifer Davis; Conrad M. Puff-Carter; Jiho Kim; Vishal Khatri; Nikhil Chauhan; Darrick Carter; Ramaswamy Kalyanasundaram
Affiliations1. Department of Biomedical Sciences, College of Medicine, University of Illinois, Rockford, USA; 2. PAI Life Sciences, Inc., Seattle, USA; 3. School of Health Sciences and Technology, UPES, Dehradun, India
Real-world effectiveness and impact of the 4CMenB vaccine against serogroup B invasive meningococcal disease: a systematic review and meta-analysis
AuthorsPavo Marijic; Katarzyna Jamróz-Dolińska; Wojciech Margas; Lucian Gaianu; Gaurav Mathur; Piotr Wojciechowski; Thatiana Pinto; Tia Vincent; Helen Petousis-Harris; Terry Nolan; Federico Martinón-Torres; Lee H. Harrison; Zeki Kocaata
Affiliations1. GSK, Munich, Germany; 2. Clever-Access, Kraków, Poland; 3. GSK, London, UK; 4. GSK, Rockville, USA; 5. GSK, Wavre, Belgium; 6. University of Auckland, Auckland, New Zealand; 7. University of Melbourne, Melbourne, Australia; 8. Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario de Santiago (SERGAS) and University of Santiago de Compostela (USC), Santiago de Compostela, Spain; 9. Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain; 10. Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain; 11. WHO Collaborating Centre for Vaccine Safety, Santiago de Compostela, Spain; 12. Center for Genomic Epidemiology, University of Pittsburgh School of Medicine, Pittsburgh, USA
Oral contraceptive usage among healthcare workers and its impact on COVID-19 booster vaccination immunogenicity
AuthorsIsabell Wagenhäuser; Julia Reusch; Juliane Mees; Lukas B. Krone; Isabella Eiter; Thiên-Trí Lâm; Alexandra Schubert-Unkmeir; Carolin Curtaz; Anna Frey; Oliver Kurzai; Stefan Frantz; Sabine Wicker; Achim Wöckel; Nils Petri; Alexander Gabel; Manuel Krone
Affiliations1. Central Laboratory Unit, University Hospital Würzburg, Würzburg, Germany; 2. Department of General, Visceral, Transplantation, Vascular, and Paediatric Surgery, University Hospital Würzburg, Würzburg, Germany; 3. Centre for Neural Circuits and Behaviour, University of Oxford, Oxford, UK; 4. University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland; 5. Institute for Hygiene and Microbiology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany; 6. Department of Obstetrics and Gynaecology, University Hospital Würzburg, Würzburg, Germany; 7. Department of Internal Medicine I, University Hospital Würzburg, Würzburg, Germany; 8. Leibniz Institute for Natural Product Research and Infection Biology – Hans-Knoell-Institute, Jena, Germany; 9. Occupational Health Service, University Hospital Frankfurt, Frankfurt am Main, Germany; 10. Department of Molecular Virology, Heidelberg University, Heidelberg, Germany
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
